Las Vegas, NV -- (SBWIRE) -- 01/14/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: U.S. Silica Holdings Inc(NYSE:SLCA), Harmony Gold Mining Co. (ADR)(NYSE:HMY), Orexigen Therapeutics, Inc.(NASDAQ:OREX), Hercules Offshore, Inc.(NASDAQ:HERO)
U.S. Silica Holdings Inc(NYSE:SLCA) was a volume gainer of 2.99 million shares and the average volume of the stock remained 1.33 million shares. The stock opened the session at $31.83 and finished at the end of the day at $29.49 and the stock plunged -7.47%.The market capitalization of the stock remained 1.57 billion. U.S. Silica Holdings, Inc., together with its subsidiaries, engages in the mining, processing, and sale of commercial silica in the United States. It operates in two segments, Oil & Gas Proppants and Industrial & Specialty Products.
Has SLCA Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Harmony Gold Mining Co. (ADR)(NYSE:HMY) exchanged 2.96 million shares and the average volume remained 2.64 million shares. The stock closed the session at $2.75 with the gain of 4.96%. Harmony Gold Mining Company Limited is engaged in the exploration, extraction, processing, and smelting of gold in South Africa and Papua New Guinea. The company also explores for uranium, silver, copper, and molybdenum. Harmony Gold Mining Company Limited was founded in 1950 and is headquartered in Randfontein, South Africa.
Will HMY Continue To Move Higher? Find Out Here
Orexigen Therapeutics, Inc.(NASDAQ:OREX) decreased -4.25% and its closing price was $6.09. The volume of the stock was 2.91 million shares and the average volume remained 2.87 million shares. The market capitalization of the stock remained 617.37 million. The beta of the stock remained 2.11. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California.
Will OREX Get Buyers Even After The Recent Rally? Find Out Here
Hercules Offshore, Inc.(NASDAQ:HERO) exchanged 2.90 million shares in the previous trading session, and its average trading remained 2.57 million shares. HERO dropped -3.29% and it closed the trading at $5.87. The market capitalization of the stock remained 937.72 million. Hercules Offshore, Inc., together with its subsidiaries, provides shallow-water drilling and marine services to the oil and natural gas exploration and production industry worldwide. The company operates through five segments: Domestic Offshore, International Offshore, Inland, Domestic Liftboats, and International Liftboats.
Has HERO Found The Bottom and Ready To Move Up? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)